The Antifungal Effects of Equol Against <i>Candida albicans</i> Involve Mitochondrial Dysfunction
Novel antifungal agents are urgently needed because of the increasing number of drug-resistant <i>Candida</i> strains encountered in clinical practice and the limited variety of available antifungal drugs. Equol, a metabolite of soy isoflavone glycosides, exhibits antifungal activities....
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-04-01
|
| Series: | Journal of Fungi |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2309-608X/11/5/339 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | Novel antifungal agents are urgently needed because of the increasing number of drug-resistant <i>Candida</i> strains encountered in clinical practice and the limited variety of available antifungal drugs. Equol, a metabolite of soy isoflavone glycosides, exhibits antifungal activities. In this study, Equol had good inhibitory activity against <i>Candida</i> species. The lowest inhibitory concentration of 125–500 μg/mL was confirmed by the gradient dilution method. In addition, transmission electron microscopy and the relative content assay showed that Equol altered the cell wall and membrane of <i>Candida albicans</i>. Further studies found that Equol treatment increased the intracellular levels of reactive oxygen species and Ca<sup>2+</sup>. Subsequent experiments suggested that Equol treatment depolarized the membrane potential of <i>C. albicans</i> and up-regulated the expression of the apoptosis-inducing factor gene. These results confirmed that Equol damaged the cell wall and membrane, dysregulated the intracellular components, induced oxidative stress and Ca<sup>2+</sup> accumulation, and ultimately resulted in mitochondrial dysfunction. Collectively, these findings demonstrated that Equol is a potential antifungal agent. |
|---|---|
| ISSN: | 2309-608X |